Bristol Myers Squibb Sees 2026 Operating Expenses at About $16.5B
Valid market news retained in the public archive without immediate LiveCast distribution.
Story updates
10:59:24 AM UTC
SquawkNews
Bristol Myers Squibb: 2026 Guidance Excludes Impact of Any Potential Future Strategic Acquisitions, Divestitures and Impact of Acquired IPRD Charges and Licensing Income Incurred After Sept. 30 >BMY